Statistics in Medicine
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Estimation of standard deviations and inverse‐variance weights from an observed range.
41:242-257.
2022
-
Estimation of diagnostic test accuracy: A “Rule of Three” for data with repeated observations but without a gold standard.
40:4815-4829.
2021
-
Meta‐analysis of quantile intervals from different studies with an application to a pulmonary tuberculosis data.
39:4519-4537.
2020
-
Correction to Walter SD, Turner RM, Macaskill P. Optimising the two‐stage randomised trial design when some participants are indifferent in their treatment preferences (2019). Statistics in Medicine 38, 2317‐2331.
39:1591-1591.
2020
-
Randomised trials with provision for early stopping for benefit (or harm): The impact on the estimated treatment effect.
38:2524-2543.
2019
-
Optimising the two‐stage randomised trial design when some participants are indifferent in their treatment preferences.
38:2317-2331.
2019
-
Methods to improve the estimation of time-to-event outcomes when data is de-identified.
38:625-635.
2019
-
Incorporation of frailties into a cure rate regression model and its diagnostics and application to melanoma data.
37:4421-4440.
2018
-
Optimal unidirectional switch designs.
37:3573-3588.
2018
-
Quantifying the bias in the estimated treatment effect in randomized trials having interim analyses and a rule for early stopping for futility.
36:1506-1518.
2017
-
The analysis of terminal endpoint events in stepped wedge designs.
35:4413-4426.
2016
-
Knowledge translation in biostatistics: a survey of current practices, preferences, and barriers to the dissemination and uptake of new statistical methods.
35:805-818.
2016
-
Inference on cancer screening exam accuracy using population-level administrative data.
35:130-146.
2016
-
The Africa Center for Biostatistical Excellence: a proposal for enhancing biostatistics capacity for sub-Saharan Africa.
34:3481-3489.
2015
-
Value of information methods for assessing a new diagnostic test.
33:1801-1815.
2014
-
Ratio of geometric means to analyze continuous outcomes in meta-analysis: comparison to mean differences and ratio of arithmetic means using empiric data and simulation.
31:1857-1886.
2012
-
Optimal allocation of participants for the estimation of selection, preference and treatment effects in the two-stage randomised trial design.
31:1307-1322.
2012
-
Testing the evolution process of prostate-specific antigen in early stage prostate cancer: what is the proper underlying model?.
30:3038-3049.
2011
-
Bayesian methods for meta-analysis of causal relationships estimated using genetic instrumental variables.
29:1298-1311.
2010
-
A geometric confidence ellipse approach to the estimation of the ratio of two variables.Statistics in Medicine2008;27:5956-5974..
28:2723-2723.
2009
-
A geometric confidence ellipse approach to the estimation of the ratio of two variables.
27:5956-5974.
2008
-
Analysis of a nonsusceptible fraction with current status data.
27:2715-2730.
2008
-
Author's Reply.
27:2734-2735.
2008
-
Use of instrumental variables in the analysis of generalized linear models in the presence of unmeasured confounding with applications to epidemiological research.
27:1539-1556.
2008
-
Effect of exposure misclassification on the mean squared error of population attributable risk and prevented fraction estimates.
26:4833-4842.
2007
-
Semi-parametric regression models for cost-effectiveness analysis: improving the efficiency of estimation from censored data.
26:3274-3299.
2007
-
Conditioning on the propensity score can result in biased estimation of common measures of treatment effect: A Monte Carlo study (p n/a) by Peter C. Austin, Paul Grootendorst, Sharon-Lise T. Normand, Geoffrey M. Anderson,Statistics in Medicine, Published Online: 16 June 2006. DOI: 10.1002/sim.2618.
26:3208-3210.
2007
-
A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study.
26:734-753.
2007
-
Conditioning on the propensity score can result in biased estimation of common measures of treatment effect: a Monte Carlo study.
26:754-768.
2007
-
Generalized gamma frailty model.
25:2797-2816.
2006
-
Correction.
25:720-720.
2006
-
Cost-effectiveness analysis for multinational clinical trials.
24:1965-1982.
2005
-
The partial area under the summary ROC curve.
24:2025-2040.
2005
-
The value of information and optimal clinical trial design.
24:1791-1806.
2005
-
1. Dicing with death: chance, risk and health. Stephen Senn, Cambridge University Press, Cambridge, 2003. No of pages: xii+251. Price:£14.99, $28.00 (paperback). ISBN: 0-521-54023-2.
24:1453-1453.
2005
-
Regression methods for cost-effectiveness analysis with censored data.
24:131-145.
2005
-
Two-sample scale tests for comparison of metabolic rates for styrene in previously exposed and unexposed groups.
23:591-599.
2004
-
Incremental net benefit in randomized clinical trials with quality-adjusted survival.
22:353-362.
2003
-
Clinical research and trials in developing countries.
21:2859-2867.
2002
-
Assessing the gain in diagnostic performance when combining two diagnostic tests.
21:2527-2546.
2002
-
A comparison of methods to detect publication bias in meta-analysis by P. Macaskill, S. D. Walter and L. Irwig,Statistics in Medicine, 2001;20:641-654.
21:1803-1803.
2002
-
Authors' Reply.
21:1804-1804.
2002
-
Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data.
21:1237-1256.
2002
-
Preface.
21:327-329.
2002
-
Bruno de Finetti: the mathematician, the statistician, the economist, the forerunner.
20:3651-3666.
2001
-
Number needed to treat (NNT): estimation of a measure of clinical benefit.
20:3947-3962.
2001
-
Cost-effectiveness analysis when the WTA is greater than the WTP.
20:3251-3259.
2001
-
Incremental net benefit in randomized clinical trials.
20:1563-1574.
2001
-
Estimating the number needed to treat (NNT) index when the data are subject to error.
20:893-906.
2001
-
A comparison of methods to detect publication bias in meta-analysis.
20:641-654.
2001
-
Methodological issues in the development of theCanadian Cancer Incidence Atlas.
19:2437-2449.
2000
-
Using an antedependence test to analyse post-operative pain measurements.
19:1889-1899.
2000
-
Meta-analysis of screening data: a survey of the literature.
18:3409-3424.
1999
-
Author's reply.
18:237-238.
1999
-
Variation in baseline risk as an explanation of heterogeneity in meta-analysis - by S. D. Walter, Statistics in Medicine, 16, 2883-2900 (1997) - Author's reply.
18:237-238.
1999
-
Variation in baseline risk as an explanation of heterogeneity in meta-analysis by S. D. Walter,Statistics in Medicine,16, 2883-2900 (1997).
18:233-237.
1999
-
Bias in the evaluation of DNA-amplification tests for detecting Chlamydia trachomatis..
17:1064-1066.
1998
-
Bias in the evaluation of DNA-amplification tests for detectingChlamydia trachomatis by A. Hadgu,Statistics in Medicine,16, 1391-1399 (1997).
17:1064-1065.
1998
-
Sample size and optimal designs for reliability studies.
17:101-110.
1998
-
Sample size and optimal designs for reliability studies.
17:101-110.
1998
-
Variation in baseline risk as an explanation of heterogeneity in meta-analysis.
16:2883-2900.
1997
-
Effects of dependent errors in the assessment of diagnostic test performance.
16:2157-2175.
1997
-
A simple test for spatial pattern in regional health data (vol 13, pg 1037, 1994).
15:335-335.
1996
-
CORRECTIONS: A SIMPLE TEST FOR SPATIAL PATTERN IN REGIONAL HEALTH DATA.
15:335-335.
1996
-
A simple test for spatial pattern in regional health data.
14:1393-1394.
1995
-
A simple test for spatial pattern in regional health data.
13:1037-1044.
1994
-
Assessing spatial patterns in disease rates.
12:1885-1894.
1993
-
Visual and statistical assessment of spatial clustering in mapped data.
12:1275-1291.
1993
-
On population and individual bioequivalence.
12:1109-1124.
1993
-
A SURVEY OF MONITORING PRACTICES IN CANCER CLINICAL-TRIALS - DATA MONITORING COMMITTEES FOR SOUTHWEST ONCOLOGY GROUP CLINICAL-TRIALS - DISCUSSION.
12:457-459.
1993
-
PRACTICAL ISSUES IN DATA MONITORING OF CLINICAL-TRIALS - SUMMARY OF RESPONSES TO A QUESTIONNAIRE AT NIH - DISCUSSION.
12:553-553.
1993
-
Preface.
12:415-415.
1993
-
Comparing in-patient classification systems: A problem of non-nested regression models.
11:1321-1331.
1992
-
CTS: A clinical trials simulator.
9:787-801.
1990
-
Cost and efficiency in clinical trials: Preface.
9:1.
1990
-
Preface.
9:1-1.
1990
-
Selection of patients for randomized controlled trials: Implications of wide or narrow eligibility criteria.
9:73-86.
1990
-
The effect of non-differential exposure misclassification on estimates of the attributable and prevented fraction.
7:1073-1085.
1988
-
Evaluating the survival of cancer cases detected by screening.
6:885-900.
1987
-
Obtaining medically meaningful answers from an overview of randomized clinical trials.
6:281-286.
1987
-
Preface.
6:217-218.
1987
-
Cause-deleted proportional mortality analysis and the healthy worker effect.
5:61-71.
1986
-
A note on optimal sampling for the comparison of proportions or rates.
4:541-542.
1985
-
Small sample estimation of log odds ratios from logistic regression and fourfold tables.
4:437-444.
1985
-
Why do we need some large, simple randomized trials?.
3:409-420.
1984
-
Effect of dependent errors in the assessment of diagnostic or screening test accuracy when the reference standard is imperfect
2012
-
Statistical issues in the design and analysis of expertise-based randomized clinical trials
2008
-
Meta‐analysis of screening data: a survey of the literature
1999
-
Variation in baseline risk as an explanation of heterogeneity in meta‐analysis
1997
-
Discission: Nancy Geller and M Stylianou, practical issues in data monitoring of clinical trials: Summary of responses to a questionnaire at NIH
1993
-
Discussion: Frank W Rockhold and G Enas, data monitoring and interim analyses in the pharmaceutical industry: Ethical and logistical considerations: George W Williams et al, monitoring of clinical trials and interim analyses from a drug sponsor's point of view
1993
-
Discussion: Stephen George, a survey of monitoring practices in cancer clinical trials: Stephanie Green and John Crowley, data monitoring committees for Southwest Oncology Group clinical trials
1993
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)